Skip to main content

Moderna's Vaccine Receives Authorization in Australia

By: ETFdb
Moderna Inc. (NasdaqGS: MRNA) surged Monday after the company’s Covid-19 vaccine was granted a provisional adult authorization in Australia, lifting biotechnology sector-related exchange traded funds.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.